# A Study to Assess the Safety and Pharmacokinetics of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Subjects

> **NCT03715114** · PHASE1 · UNKNOWN · sponsor: **Shanghai Greenvalley Pharmaceutical Co., Ltd.** · enrollment: 45 (estimated)

## Conditions studied

- Pharmacokinetics
- Safety

## Interventions

- **DRUG:** GV-971
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03715114
- **Lead sponsor:** Shanghai Greenvalley Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-15
- **Primary completion:** 2018-11-30
- **Final completion:** 2018-12-31
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2018-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03715114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03715114, "A Study to Assess the Safety and Pharmacokinetics of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03715114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*